The content of this book is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 Unported license. To view the terms and conditions of this license, visit https://creativecommons.org/licenses/by-nc-nd/4.0/
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Varki A, Cummings RD, Esko JD, et al., editors. Essentials of Glycobiology [Internet]. 4th edition. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 2022.
Table 1
Disorder | Gene | Function | Disorder OMIM | Gene OMIM | Main clinical features | Year | Reference |
---|---|---|---|---|---|---|---|
N-linked pathway | |||||||
DPAGT1–CDG | DPAGT1 | GlcNAc-1-P transferase | 608093 | 191350 | ID, Hy, Sz, M, infections, early death, CMS | 2003 | PMID: 12872255 |
ALG1–CDG | ALG1 | β1-4 mannosyltransferase | 608540 | 605907 | ID, Hy, Sz, M, infections, early death | 2004 |
PMID: 14709599
PMID: 14973778 PMID: 14973782 |
ALG2–CDG | ALG2 | α1-3 mannosyltransferase | 607906 | 607905 | ID, Hy, Sz, infections, hypomyelination, hepatomegaly, early death | 2003 | PMID: 12684507 |
ALG2–CMS | CMS | 2013 | PMID: 23404334 | ||||
ALG3–CDG | ALG3 | α1-3 mannosyltransferase | 601110 | 608750 | ID, Hy, Sz, M, optic nerve atrophy | 1999 | PMID: 10581255 |
ALG6–CDG | ALG6 | α1-3 glucosyltransferase | 603147 | 604566 | ID, Hy, Sz, M, ataxia | 1999 | PMID: 10359825 |
ALG8–CDG | ALG8 | α1-3 glucosyltransferase | 608104 | 608103 | DD, hepatomegaly, protein-losing enteropathy, coagulopathy, ascites, renal failure, early death | 2003 | PMID: 12480927 |
ALG9–CDG | ALG9 | α1-2 mannosyltransferase | 608776 | 606941 | ID, Hy, Sz, hepatomegaly | 2004 | PMID: 15148656 |
ALG10–CDG | ALG10 | α1,2-Glucosyltransferase | N/A | 618355 | Progressive myoclonus epilepsy | 2021 | PMID: 33798445 |
ALG11–CDG | ALG11 | α1-2 mannosyltransferase | 613661 | 613666 | ID, Hy, Sz, deafness, dysmorphism | 2010 | PMID: 20080937 |
ALG12–CDG | ALG12 | α1-6 mannosyltransferase | 607143 | 607144 | ID, Hy, Sz, M, recurrent infections | 2002 |
PMID: 11983712
PMID: 12217961 |
ALG13–CDG | ALG13 | UDP-GlcNAc transferase | 300884 | 300776 | M, Sz, hepatomegaly, horizontal nystagmus, optic nerve atrophy, infections | 2012 | PMID: 22492991 |
ALG14-CMS | ALG14 | UDP-GlcNAc transferase | 616227 | 612866 | CMS | 2013 | PMID: 23404334 |
ALG14–CDG |
619036 | epilepsy, cerebral atrophy | 2017 | PMID: 28733338 | |||
RFT1–CDG | RFT1 | Man5GlcNAc2 flippase | 612015 | 611908 | ID, Hy, Sz, M, hepatomegaly, coagulopathy, deafness | 2008 | PMID: 18313027 |
STT3A–CDG (recessive) | STT3A | subunit of the OST complex | 615596 | 601134 | ID, DD, H, M, Sz, failure to thrive | 2013 | PMID: 23842455 |
STT3A-CDG (dominant) | Variable skeletal anomalies, short stature, dysmorphic features, ID, and increased muscle tone and muscle cramps. | 2021 | |||||
STT3B–CDG | STT3B | subunit of the OST complex | 615597 | 608605 | ID, DD, H, M, Sz, failure to thrive, thrombocytopenia, genital abnormalities | 2013 | PMID: 23842455 |
MAGT1–CDG | MAGT1 | subunit of the OST complex | 300716 | 300715 | XLNSID | 2008 | PMID: 18455129 |
TUSC3–CDG | TUSC3 | subunit of the OST complex | 611093 | 601385 | NSID | 2008 |
PMID: 18452889
PMID: 18455129 |
DDOST–CDG | DDOST | subunit of the OST complex | 614507 | 602202 | ID, DD, failure to thrive, gastroesophageal reflux, ear infections, oromotor dysfunction | 2012 | PMID: 22305527 |
OSTc–CDG | OSTc | subunit of the OST complex | N/A | 619023 | M, dysmorphic facies, congenital heart defect, focal epilepsy, IS, skeletal dysplasia and was fatal. | 2020 | PMID: 32267060 |
TREX-CDG | TREX1 | OST chaperone |
152700 | 606609 | autoimmune and autoinflammatory diseases | 2015 | PMID: 26320659 |
NGLY1–CDG | NGLY1 | N-glycanase-1 | 615273 | 610661 | ID, DD, Sz, abnormal liver function | 2012 | PMID: 22581936 |
MAN2C1-CDG | MAN2C1 | free oligosaccharide processing | N/A | 154580 | ID, brain abnormalities, dysmorphic facies | 2021 | |
SSR3–CDG | SSR3 | signal sequence receptor, gamma | N/A | 606213 | Sz, ID, DD, M, abnormal brain structure | 2019 | PMID: 30945312 |
SSR4–CDG | SSR4 | signal sequence receptor, delta | 300934 | 300090 | M, ID, Sz, gastroesophageal reflux | 2013 | PMID: 24218363 |
MGAT2–CDG | MGAT2 | GlcNAc-transferase II | 212066 | 602616 | ID, feeding problems, severe diarrhea, growth retardation, dysmorphism | 1996 | PMID: 8808595 |
MOGS–CDG | MOGS | α1-2 glucosidase | 606056 | 601336 | Hy, Sz, hepatomegaly, hypoventilation, feeding problems, dysmorphism, fatal, unique tetrasaccharide in urine | 2000 | PMID: 10788335 |
Autosomal-Dominant Polycystic Kidney and Liver Disease | GANAB | α1-3 glucosidase | 600666 | 104160 | autosomal-dominant polycystic kidney and liver disease | 2016 | PMID: 27259053 |
MAN1B1–CDG | MAN1B1 | α1-2 mannosidase | 614202 | 604346 | NSID, delayed motor and speech development, variable dysmorphic features, truncal obesity, macrocephaly | 2011 | PMID: 21763484 |
I-cell disease | GNPTAB | GlcNAc-1-P transferase | 252500 252600 | 607840 | ID, congenital dislocation of the hip, thoracic deformities, hernia, hyperplastic gums, coarse facial features, restricted joint movement | 1981 | PMID: 6461005 |
Autosomal-dominant polycystic liver disease | PRKCSH | glucosidase II subunit β | 174050 | 177060 | autosomal-dominant polycystic liver disease | 2003 |
PMID: 12529853
PMID: 12577059 |
Congenital severe neutropenia | JAGN1 | endoplasmic reticulum organization | 616022 | 616012 | congenital severe neutropenia, recurrent infections | 2014 |
PMID: 25129144
PMID: 25129145 |
FUT8-CDG | FUT8 | α1-6 fucosyltransferase | 602589 | Severe DD, growth retardation, feeding problems, short stature, respiratory difficulties | 2017 | ||
MAN2A2-CDG | MAN2A2 | Golgi Alpha-Mannosidase II |
N/A | 600988 | ID, DD |
* | |
EDEM3-CDG | EDEM3 | ER Degradation Enhancing Alpha-Mannosidase Like Protein 3 | 610214 | Neurodevelopmental delay and variable facial dysmorphisms | 2021 | ||
Potential to effect multiple pathways | |||||||
PMM2–CDG | PMM2 | conversion of Man-6-P to Man-1-P | 212065 | 601785 | ID, Hy, Sz, strabismus, cerebellar hypoplasia, failure to thrive, cardiomyopathy, 20% lethality in the first 5 yr | 1997 | PMID: 9140401 |
MPI–CDG | MPI | conversion of Fruct-6-P and Man-6-P | 602579 | 154550 | Hepatic fibrosis, coagulopathy, hypoglycemia, protein-losing enteropathy, vomiting, no neurological symptoms | 1998 | PMID: 9525984 |
DHDDS–CDG (recessive) | DHDDS | dehydrodolichol diphosphate synthase | 613861 | 608172 | Retinitis pigmentosa in Ashkenazi Jews | 2011 |
PMID: 21295282
PMID: 21295283 |
DHDDS-CDG (dominant) | 617836 | DD, Sz, neurodegeneration | 2021 | PMID: 34382076 | |||
NUS1–CDG (recessive) | NUS1 | dehydrodolichol diphosphate synthase | 617082 | 610463 | DD, ID, Sz, Hy | 2014 | PMID: 25066056 |
MRD55 (dominant) | Mental retardation, autosomal dominant 55, with seizures |
2017 | PMID: 29100083 | ||||
DOLK–CDG | DOLK | Dol kinase | 610768 | 610746 | ID, Hy, Sz, hypoglycemia, ichthyosis, dilated cardiomyopathy, cardiac failure | 2007 | PMID: 17273964 |
SRD5A3–CDG | SRD5A3 | polyprenol reductase | 612379 | 611715 | ID, Hy, eye and brain malformations, nystagmus, hepatic dysfunction, coagulopathy, ichthyosis | 2010 | PMID: 20637498 |
DPM1–CDG | DPM1 | Dol-P-Man synthase complex | 608799 | 603503 | ID, Hy, Sz, M, dysmorphism, coagulopathy | 2000 |
PMID: 10642597
PMID: 10642602 |
DPM2–CDG | DPM2 | Dol-P-Man synthase complex | 615042 | 603564 | dystroglycanopathy, Sz, Hy, M, dysmorphism, cerebellar hypoplasia, early death | 2012 | PMID: 23109149 |
DPM3–CDG | DPM3 | Dol-P-Man synthase complex | 612937 | 605951 | dystroglycanopathy, dilated cardiomyopathy, stroke-like episode | 2009 | PMID: 19576565 |
MPDU1–CDG | MPDU1 | Man-P-Dol utilization | 609180 | 604041 | ID, Sz, failure to thrive, ichthyosis-like skin disorder, severe feeding difficulties | 2001 |
PMID: 11733556
PMID: 11733564 |
FCSK-CDG | FCSK | Fucose Kinase | 618324 | 608675 | severe DD, encephalopathy, intractable Sz, and Hy | 2018 | PMID: 30503518 |
GFUS-CDG | GFUS | GDP-L-fucose synthase | N/A | 137020 | DD, mild coarse facial features | 2021 | PMID: 34468083 |
GMPPA–CDG | GMPPA | GDP-Man pyrophosphorylase A | 615510 | 615495 | achalasia, alacrima, neurological deficits | 2013 | PMID: 24035193 |
B4GALT1–CDG | B4GALT1 | β1-4 galactosyltransferase | 607091 | 137060 | ID, DD, Hy, macrocephaly, Dandy–Walker malformation, coagulopathy, myopathy | 2002 | PMID: 11901181 |
SLC35A1–CDG | SLC35A1 | CMP-sialic acid transporter | 603585 | 605634 | ID, Sz, ataxia, bleeding, thrombocytopenia, neutropenia, renal and cardiac involvement | 2005 2013 |
PMID: 15576474
PMID: 23873973 |
SLC35A2–CDG | SLC35A2 | UDP-Gal transporter | 300896 | 314375 | ID, Sz, skeletal anomalies | 2013 | PMID: 23561849 |
SLC35A3–CDG | SLC35A3 | UDP-GlcNAc transporter | 615553 | 605632 | autism spectrum disorder, Hy, epilepsy, arthrogryposis | 2013 | PMID: 24031089 |
SLC39A8–CDG | SLC39A8 | manganese transporter | 616721 | 608732 | cranial asymmetry, severe infantile spasms with hypsarrhythmia, dysproportionate dwarfism | 2015 | PMID: 26637979 PMID: 26637978 |
SLC35C1–CDG | SLC35C1 | GDP-Fuc transporter | 266265 | 605881 | ID, Hy, Sz, M, unusual facial appearance, dwarfism, infections with neutrophilia | 2001 | PMID: 11326279 |
COG1–CDG | COG1 | Golgi-to-ER retrograde transport | 611209 | 606973 | ID, shortened long bones, facial dysmorphism | 2006 | PMID: 16537452 |
COG1–CCMS | CCMS | 2009 | PMID: 19008299 | ||||
COG2–CDG | COG2 | Golgi-to-ER retrograde transport | 606974 | M, psychomotor retardation, Sz, liver dysfunction, hypocupremia, hypoceruloplasminemia | 2014 | PMID: 24784932 | |
COG3–CDG | COG3 | Golgi-to-ER retrograde transport | N/A | 606975 | severe DD, Hy, cerebral and cerebellar atrophy | 2021 | * |
COG4–CDG (recessive) | COG4 | Golgi-to-ER retrograde transport | 613489 | 606976 | DD, Hy, Sz, nystagmus, hepatosplenomegaly, failure to thrive in infancy with recurrent diarrhea, early death | 2009 | PMID: 19494034 |
Saul-Wilson syndrome (dominant) |
dwarfism, DD, characteristic facial and radiographic features |
2018 | |||||
COG5–CDG | COG5 | Golgi-to-ER retrograde transport | 613612 | 606821 | ID, Hy, delayed speech, ataxia | 2009 | PMID: 19690088 |
COG6–CDG | COG6 | Golgi-to-ER retrograde transport | 614576 | 606977 | severe neurologic disorder, Sz, vomiting | 2010 | PMID: 20605848 |
COG7–CDG | COG7 | Golgi-to-ER retrograde transport | 608779 | 606978 | Hy, M, growth retardation, adducted thumbs, failure to thrive, cardiac anomalies, wrinkled skin, early death | 2004 | PMID: 15107842 |
COG8 – CDG | COG8 | Golgi-to-ER retrograde transport | 611182 | 606979 | ID, Hy, Sz | 2007 |
PMID: 17331980
PMID: 17220172 |
ATP6V0A2–CDG wrinkly skin syndrome | ATP6V0A2 | Golgi pH regulator | 219200 278250 | 611716 | cutis laxa, congenital hip dislocation, joint hyperlaxity, dysmorphism, feeding problems, late closure of the fontanelles, varying CNS involvement | 2008 | PMID: 18157129 |
TMEM165–CDG | TMEM165 | Golgi pH regulator and, manganese and calcium homeostasis | 614727 | 614726 | ID, Hy, M, short stature, dysmorphism, eye abnormalities, hepatomegaly, skeletal dysplasia | 2012 | PMID: 22683087 |
TMEM199–CDG | TMEM199 | Golgi homeostasis | 616829 | 616815 | mild phenotype of hepatic steatosis, elevated aminotransferases, alkaline phosphatase, hypercholesterolemia, low serum ceruloplasmin | 2016 |
PMID |
CCDC115–CDG | CCDC115 | Golgi homeostasis | 616828 | 613734 | storage-disease-like phenotype involving hepatosplenomegaly, which regressed with age, highly elevated bone-derived alkaline phosphatase, elevated aminotransferases, and elevated cholesterol, in combination with abnormal copper metabolism and neurological symptoms | 2016 |
PMID |
ATP6AP1-CDG | ATP6AP1 | Golgi vacuolar ATPase | 300197 | immunodeficiency, hepatopathy, and variable neurocognitive abnormalities | 2016 | PMID: 27231034 | |
ATP6AP2-CDG | ATP6AP2 | Golgi vacuolar ATPase | 300556 | ID, liver disease, immunodeficiency, cutis laxa | 2017 | ||
ATP6V1A-CDG | ATP6V1A | Golgi vacuolar ATPase | 617403 | 607027 | cutis laxa, facial dysmorphism, cardiac abnormalities | 2017 | PMID: 28065471 |
ATP6V1E1-CDG | ATP6V1E1 | Golgi vacuolar ATPase | 617402 | 108746 | cutis laxa, facial dysmorphism, cardiac abnormalities | 2017 | PMID: 28065471 |
VMA21-CDG | VMA21 | V-ATPase assembly factor | 310440 | 300913 | Mild cholestasis, chronic elevation of transaminases, elevation of (LDL) cholesterol and steatosis | 2020 | PMID: 32145091 |
MRX108 | SLC9A7 | Na(+)/H(+) Exchanger | 301024 | 300368 | Nonsyndromic form of X-linked ID | 2019 | PMID: 30335141 |
Congenital myasthenic syndrome | GFPT1 | glutamine-fruct-6-P transaminase 1 | 610542 | 138292 | congenital myasthenic syndrome with tubular aggregates | 2011 | PMID: 21310273 |
Achondrogenesis type 1A | TRIP11 | Golgi structure | 200600 | 604505 | lethal achondrogenesis, deficient ossification | 2010 | PMID: 20089971 |
PGM1–CDG Glycogen storage disease 14 | PGM1 | reversible conversion of Glc-1-P and Glc-6-P | 614921 612934 | 171900 | neurologically normal, split uvula, hepatopathy, hypoglycemia, rhabdomyolysis, dilated cardiomyopathy, cardiac arrest, malignant hyperthermia | 2012 | PMID: 22492991 |
HIES | PGM3 | reversible conversion of GlcNAc-1-P and GlcNAc-6-P | 615816 | 172100 | severe atopy, increased serum IgE levels, immune deficiency, autoimmunity, motor and neurocognitive impairment | 2014 |
PMID: 24589341
PMID: 24698316 |
Neutropenia, severe congenital 4 | G6PC3 | Glc-6 phosphatase, catalytic, 3 | 612541 | 611045 | severe congenital neutropenia, recurrent infections, prominent superficial veins, cardiac abnormalities | 2011 | PMID: 21385794 |
Glycogen storage disease Ib and Ic (recessive) | SLC37A4 | Glc-6-P transporter | 232220 232240 | 602671 | neutrophil dysfunction | 2011 | PMID: 21385794 |
SLC37A4-CDG (dominant) | 619525 | Liver dysfunction, coagulation deficiencies | 2021 | PMID: 33964207 | |||
NSID West syndrome | ST3GAL3 | N-acetyllactosaminide α2-3 sialyltransferase | 611090 615006 | 606494 | NSID, infantile spasms, hypsarrhythmia | 2011 2013 |
PMID: 21907012
PMID: 23252400 |
CDA-II | SEC23B | Golgi trafficking | 224100 | 610512 | disrupted erythropoiesis with multinucleated erythroblasts in bone marrow | 2009 | PMID: 19561605 |
Autosomal-dominant polycystic liver disease | SEC63 | Golgi trafficking | 174050 | 608648 | autosomal-dominant polycystic liver disease | 2004 | PMID: 15133510 |
STX5-CDG | STX5 | Golgi | N/A | 603189 | Multisystem disease with severe liver disease, skeletal dysplasia, facial dysmorphism, hypotonia, elevated cholesterol | 2021 |
PMID |
GET2-CDG | CAMLG | Transmembrane Domain Recognition Complex | N/A | 601118 | DD, ID, Hy, epilepsy | 2021 | * |
GET3-CDG | GET3 | Transmembrane Domain Recognition Complex | N/A | 601913 | Progressive pediatric cardiomyopathy and early death | 2019 | PMID: 31461301 |
GET4-CDG | GET4 | Transmembrane Domain Recognition Complex | N/A | 612056 | DD, ID, Sz, facial dysmorphism, and delayed bone age | 2020 | PMID: 32395830 |
Catel-Manzke syndrome | TGDS | TDP-Glc 4,6-dehydratase | 616145 | 616146 | Pre and postnatal growth deficiency, Pierre Robin anomaly, cardiac abnormalities, distinctive bilateral hyperphalangy of the index finger. | 2014 | PMID: 25480037 |
TRAPPC11- deficiency | TRAPPC11 | Intracellular vesicle trafficking | 615356 | 614138 | Muscular dystrophy, limb-girdle or cerebral atrophy, global retardation, scoliosis, achalasia and alacrima. | 2017 |
PMID: 23830518
PMID: 27707803 |
TRAPPC9-CDG | TRAPPC9 | Intracellular vesicle trafficking | 613192 | 611966 | ID, microcephaly, hypoplastic corpus callosum, dysmorphic features | 2022 |
PMID |
UGP2-CDG Developmental and epileptic encephalopathy 83 | UGP2 | UDP-Glc pyrophosphorylase 2 (converts Glc-1-P to UDP-Glc) | 618744 | 191760 | ID, Sz, DD, Hy, feeding difficulties, Dysmorphic facial features in some | 2020 | PMID: 31820119 |
UGDH-CDG Developmental and epileptic encephalopathy 84 | UGDH | UDP-Glc dehydrogenase (converts UDP-Glc to UDP-GlcA) | 618792 | 603370 | ID, Sz, DD, Hy, feeding difficulties, Dysmorphic facial features in some | 2020 | PMID: 32001716 |
Developmental and epileptic encephalopathy-50 (DEE50) CAD-CDG | CAD | de novo pyrimidine biosynthesis | 616457 | 114010 | DD, Hy, epileptic encephalopathy | 2015 | PMID: 25678555 |
Cohen syndrome | VPS13b | Vacuolar Protein Sorting 13 Homolog B | 216550 | 607817 | ID, M, facial dysmorphism, truncal obesity, progressive retinopathy, and intermittent congenital neutropenia | 2003 | PMID: 24334764 |
GPI-anchor pathway | |||||||
X-linked GPI-anchor deficiency (GPIBD4) | PIGA | GlcNAc-PI synthesis protein | 300868 | 311770 | dysmorphism, Hy, Sz, variable CNS, cardiac, urinary systems, early death | 2012 | PMID: 22305531 |
Paroxysmal nocturnal hemoglobinuria | 300818 | Complement-mediated hemolysis | 1993 | PMID: 8500164 | |||
Autosomal-recessive GPI-anchor deficiency (GPIBD16) | PIGC | GlcNAc-PI synthesis protein | 617816 | 601730 | DD/ID, Sz | 2016 | PMID: 27694521 |
Autosomal-recessive GPI-anchor deficiency (GPIBD17) | PIGH | GlcNAc-PI synthesis protein | 618010 | 600154 | Sz, moderate DD | 2018 | |
Autosomal-recessive GPI-anchor deficiency (GPIBD19) | PIGQ | GlcNAc-PI synthesis protein | 618548 | 605754 | severe DD, SZ, early death | 2014 | PMID: 24463883 |
Autosomal-recessive GPI-anchor deficiency (GPIBD14) | PIGP | GlcNAc-PI synthesis protein | 617599 | 605938 | DD, Hy, Sz | 2017 | PMID: 28334793 |
Autosomal-recessive GPI-anchor deficiency (GPIBD12) | PIGY | GlcNAc-PI synthesis protein | 616809 | 610662 | severe DD, Sz, early death | 2015 | PMID: 26293662 |
CHIME syndrome HPMRS (GPIBD5) | PIGL | GlcNAc-PI de-N-acetylase | 280000 | 605947 | ID, colobomas, heart defect, early-onset ichthyosiform dermatosis, ear anomalies (conductive hearing loss), HPMRS | 2012 | PMID: 22444671 |
West syndrome and HPMRS (GPIBD11) | PIGW | acylates the inositol ring of phosphatidylinositol in GPI-anchor biosynthesis | 616025 | 610275 | West syndrome, HPMRS | 2013 | PMID: 24367057 |
Autosomal-recessive GPI-anchor deficiency (GPIBD1) | PIGM | first α-mannosyltransferase in GPI biosynthesis | 610293 | 610273 | Sz, portal vein thrombosis, portal hypertension | 2006 | PMID: 16767100 |
HPMRS (GPIBD2) | PIGV | second α-mannosyltransferase in GPI biosynthesis | 239300 | 610274 | HPMRS 1 | 2010 | PMID: 20802478 |
Autosomal-recessive GPI-anchor deficiency (GPIBD3) | PIGN | GPI ethanolamine phosphate transferase 1 | 614080 | 606097 | severe neurologic impairment, Sz, lack of development, multiple congenital anomalies, early death | 2011 | PMID: 21493957 |
Autosomal-recessive GPI-anchor deficiency (GPIBD20) | PIGB | third α-mannosyltransferase in GPI biosynthesis | 618580 | 604122 | DD/ID, Hy, Sz, hyperphosphatasia | 2019 | |
Paroxysmal nocturnal hemoglobinuria |
Complement-mediated hemolysis |
2020 | |||||
Autosomal-recessive GPI-anchor deficiency (GPIBD24) | PIGF | GPI ethanolamine phosphate transferase 2/3 | 619356 | 600153 |
onychodystrophy, osteodystrophy, ID, SZ | 2021 | |
HPMRS (GPIBD6) | PIGO | GPI ethanolamine phosphate transferase 3 | 614749 | 614730 | HPMRS 2 | 2012 | PMID: 22683086 |
Autosomal-recessive GPI-anchor deficiency (GPIBD13) | PIGG | GPI ethanolamine phosphate transferase 2 | 616917 | 616918 | DD/ID, Hy, Sz | 2016 | PMID: 26996948 |
Autosomal-recessive GPI-anchor deficiency (GPIBD22) | PIGK | GPI transamidase complex | 618879 | 605087 | DD/ID, Sz, ataxia | 2020 | |
Autosomal-recessive GPI-anchor deficiency (GPIBD18) | PIGS | GPI transamidase complex | 618143 | 610271 | DD/ID, Hy, Sz | 2018 | |
Autosomal-recessive GPI-anchor deficiency (GPIBD7) | PIGT | GPI transamidase complex | 615398 | 610272 | ID, Hy, Sz, abnormal skeletal, endocrine, ophthalmologic abnormalities, hypophosphatasia | 2013 | PMID: 23636107 |
Paroxysmal nocturnal hemoglobinuria | 615399 | Complement-mediated hemolysis | 2013 | PMID: 23733340 | |||
Autosomal-recessive GPI-anchor deficiency (GPIBD21) | PIGU | GPI transamidase complex | 618590 | 608528 | DD/ID, Hy, Sz | 2019 | |
Autosomal-recessive GPI-anchor deficiency (GPIBD15) | GPAA1 | GPI transamidase complex | 617810 | 603048 | DD, Hy, Sz, cerebellar atrophy, osteopenia | 2017 | |
Autosomal-recessive GPI-anchor deficiency (GPIBD9) | PGAP1 | lipid remodeling steps of GPI-anchor maturation | 615802 | 611655 | ID with encephalopathy | 2014 | PMID: 24784135 |
HPMRS (GPIBD8) | PGAP2 | lipid remodeling steps of GPI-anchor maturation | 614207 | 615187 | HPMRS 3 | 2013 |
PMID: 23561846
PMID: 23561847 |
HPMRS (GPIBD10) | PGAP3 | lipid remodeling steps of GPI-anchor maturation | 615716 | 611801 | HPMRS 4 | 2014 | PMID: 24439110 |
Early infantile epileptic encephalopathy (GPIBD23) | ARV1 | associates with GlcNAc-PI synthesis enzyme, putative lipid transporter | 617020 | 611647 | ID, Hy, Sz, encephalopathy, ataxia, visual impairment | 2020 | PMID: 32165008 |
Dystroglycanopathy | |||||||
Walker–Warburg syndrome (MDDGA1, B1, C1) | POMT1 | O-mannosyltransferase | 236670 613155 609308 | 607423 | Walker–Warburg syndrome, brain malformations, various eye malformations, elevated serum CK | 2002 | PMID: 12369018 |
Walker–Warburg syndrome (MDDGA2, B2, C2) | POMT2 | O-mannosyltransferase | 613150 613156 613158 | 607439 | Walker–Warburg syndrome, brain malformations, various eye malformations, elevated serum CK | 2005 | PMID: 15894594 |
Muscle–eye–brain disease (MDDGA3, B3, C3) | POMGNT1 | O-mannosyl glycan GlcNAc-transferase | 253280 613151 613157 | 606822 | ID, severe early-onset muscle weakness, brain malformations, various eye malformations, elevated serum CK | 2001 | PMID: 11709191 |
Fukuyama-type congenital muscular dystrophy (MDDGA4, B4, C4) | FKTN | ribitol-5-phosphate transferase | 253800 613152 611588 | 607440 | Hy, ID, Sz, generalized muscle weakness, elevated serum CK | 1998 | PMID: 9690476 |
Congenital muscular dystrophy type 1C (MDDGA5, B5, C5) | FKRP | fukutin-related protein, ribitol-5-phosphate transferase | 613153 606612 607155 | 606596 | Hy, feeding difficulties, hypertrophy of lower limb muscles, wasting of shoulder girdle, variable neurological involvement, elevated serum CK | 2001 | PMID: 11592034 |
Congenital muscular dystrophy type 1D (MDDGA6, B6) | LARGE1 | Xyl and GlcA transferase | 613154 608840 | 603590 | ID, white matter changes, elevated serum CK | 2003 | PMID: 12966029 |
Walker–Warburg syndrome (MDDGA7) | CRPPA | CDP-ribitol synthetase | 614643 | 614631 | brain malformations, various eye malformations, elevated serum CK | 2012 |
PMID: 22522420
PMID: 22522421 |
Walker–Warburg syndrome (MDDGA8) | POMGNT2 | β1-4 GlcNAc-transferase | 614830 | 614828 | brain malformations, various eye malformations | 2012 | PMID: 22958903 |
Walker–Warburg syndrome (MDDGA10) | RXYLT1 | Xyl-transferase | 615041 | 605862 | brain malformations, facial clefts, retinal dysplasia, gonadal dysgenesis. | 2012 | PMID: 23217329 |
Congenital muscular dystrophy (MDDGA11) | B3GALNT2 | β1-3 GalNAc-transferase 2 | 615181 | 610194 | I.D, Hy, Sz, brain malformations, various eye malformations, elevated serum CK | 2013 | PMID: 23453667 |
Walker–Warburg syndrome (MDDGA12) | POMK | O-Man kinase | 615249 | 615247 | Walker–Warburg syndrome, brain and eye malformations, elevated serum CK | 2013 |
PMID: 23929950
PMID: 23519211 |
Walker–Warburg syndrome (MDDGA13) | B4GAT1 | β1-4 glucuronyltransferase | 615287 | 605517 | Hy, Sz, brain malformations, retinal dysplasia, elevated serum CK | 2013 | PMID: 23359570 |
Congenital muscular dystrophy (MDDGA14, B14, C14) | GMPPB | GDP-Man pyrophosphorylase B | 615350 615351 615352 | 615320 | I.D, M, brain and eye malformations, elevated serum CK | 2013 | PMID: 23768512 |
Hereditary inclusion body myopathy | GNE | UDP-GlcNAc-2-epimerase/ManAc kinase | 600737 605820 269921 | 603824 | proximal and distal muscle weakness, wasting of the upper and lower limbs, sparing of the quadriceps | 2001 | PMID: 11528398 |
Glycosaminoglycan | |||||||
Ehlers–Danlos syndrome | B4GALT7 | β1-4 galactosyltransferase 7 | 130070 | 604327 | progeroid form with DD, short stature, osteopenia, defective wound healing, hypermobile joints, hypotonic muscles, loose but elastic skin | 1990 | PMID: 2106134 |
Hereditary multiple exostoses | EXT1 | GlcA/GlcNAc-transferase | 133700 | 608177 | multiple exostoses of the bone | 1995 | PMID: 7550340 |
Hereditary multiple exostoses (dominant) | EXT2 | GlcA/GlcNAc-transferase | 133700 | 608210 | multiple exostoses of the bone | 1995 | PMID: 7550340 |
Seizures, scoliosis, and macrocephaly syndrome (recessive) | 616682 | 2015 | PMID: 26246518 | ||||
Schneckenbecken dysplasia | SLC35D1 | UDP-GlcA / UDP-GalNAc Golgi transporter | 269250 | 610804 | neonatal lethal chondrodysplasia, short-limbed skeletal dysplasia | 2007 | PMID: 17952091 |
SED | PAPSS2 | 3′-phosphoadenosine- 5′-phosphosulphate synthase | 612847 | 603005 | short-trunk stature, skeletal dysplasia, normal intelligence, variable epiphyseal and metaphyseal changes | 1998 | PMID: 9771708 |
Achondrogenesis type 1B | SLC26A2 | sulfate anion transporter | 222600 600972 256050 | 606718 | early death in severe cases, adults reported: achondrogenesis Ib, usually stillborn or early death of respiratory failure; atelosteogenesis II, pulmonary hypoplasia, fatal in infants | 1996 | PMID: 8528239 |
SED, Omani type | CHST3 | chondroitin 6-O-sulfotransferase | 143095 | 603799 | skeletal dysplasia, normal intelligence | 2004 | PMID: 15215498 |
Macular corneal dystrophy types I/II | CHST6 | Keratan Sulphate 6-O-sulfotransferase | 217800 | 605294 | corneal clouding and erosions, painful photophobia | 2000 | PMID: 11017086 |
Osteochondrodysplasia, brachydactyly, and overlapping malformed digits | CHST11 | Chondroitin 4-O-Sulfotransferase 1 | 618167 | 610128 | Skeletal malformation | 2015 | PMID: 26436107 |
Ehlers–Danlos syndrome Adducted thumb-clubfoot syndrome | CHST14 | dermatan sulfate GalNAc 4-O sulfotransferase 1 | 601776 | 608429 | adducted thumb, clubfoot, progressive joint, skin laxity syndrome | 2009 2010 |
PMID: 20004762
PMID: 20533528 |
Desbuquois dysplasia 1 Epiphyseal dysplasia, multiple, 7 | CANT1 | Calcium Activated Nucleotidase 1 |
251450
| 613165 | Severe growth delay, joint laxity, short extremities, scoliosis | 2009 | PMID: 19853239 |
Ehlers–Danlos-like syndrome or SED with joint hyperlaxity | B3GALT6 | β1-3 galactosyltransferase 6 | 271640 615349 | 615291 | abnormal skeletal and connective tissues lax skin, muscle hypotonia, joint dislocation, spinal deformity | 2013 | PMID: 23664117 |
Larsen-like syndrome | B3GAT3 | β1-3 glucuronyltransferase 3 | 245600 | 606374 | multiple joint dislocations, short stature, craniofacial dysmorphism, congenital heart defects | 2011 | PMID: 21763480 |
Desbuquois dysplasia | FAM20B | Glycosaminoglycan xylosylkinase | N/A | 611063 | short limb dysplasia, very short stature, joint laxity and skeletal changes | 2019 | PMID: 30847897 |
Autosomal-recessive short stature syndrome (Desbuquois dysplasia 2) | XYLT1 | Xyl-transferase 1 | 615777 | 608124 | moderate ID, short stature, distinct facial features, altered fat distribution | 2014 | PMID: 23982343 |
Spondyloocular syndrome with bone fragility, cataracts, and hearing defects | XYLT2 | Xyl-transferase 2 | 605822 | 608125 | osteoporosis, cataracts, sensorineural hearing loss, mild learning defects | 2015 | PMID: 26027496 |
Musculocontractural type of Ehlers–Danlos syndrome | DSE | dermatan sulfate epimerase | 615539 | 605942 | characteristic facial features, congenital contractures of the thumbs and feet, hypermobility of finger, elbow, and knee joints, muscle weakness | 2013 | PMID: 23704329 |
CSGALNACT1 deficiency |
CSGALNACT1 |
chondroitin sulfate N-acetylgalactosaminyltransferase-1 | 616615 | short stature and joint laxity | 2017 | PMID: 27599773 | |
EXTL3 deficiency |
EXTL3 |
GlcA/GlcNAc-transferase | 605744 | ID, skeletal dysplasia, Severe combined immunodeficiency | 2017 | ||
SLC10A7 deficiency |
SLC10A7 |
Ca2+ homeostasis | 611459 | Amelogenesis imperfecta and skeletal dysplasia with multiple dislocations | 2018 | ||
NDST1-CDG MRT46 |
NDST1 |
N-deacetylates and N-sulfates GlcNAc in heparan sulfate | 600853 | Nonsyndromic ID | 2014 | ||
Paganini-Miozzo syndrome (MRXSPM) |
HS6ST2 |
Heparan Sulfate 6-O-Sulfotransferase 2 | 300545 | XLID and severe myopia | 2019 | ||
Neurofacioskeletal syndrome with or without renal agenesis |
HS2ST1 |
Heparan Sulfate 6-O-Sulfotransferase 1 | 604844 | DD/ID, corpus callosum hypoplasia or agenesis, facial dysmorphism, skeletal abnormalities | 2020 | ||
Temtamy preaxial brachydactyly syndrome |
CHSY1 |
β1–3 GlcA-transferase/ β1–4 GalNAc-transferase (CS elongation) | 608183 | Bilateral, symmetric preaxial brachydactyly and hyperphalangism of digits, facial dysmorphism, dental anomalies, sensorineural hearing loss, delayed motor, growth retardation, ID | 2010 | ||
Other | |||||||
Amish infantile epilepsy | ST3GAL5 | Sia2,3Galβ1-4Glc-Cer synthase (GM3) | 609056 | 604402 | infantile-onset epilepsy, developmental stagnation, blindness | 2004 | PMID: 15502825 |
Salt and pepper syndrome |
severe ID, epilepsy, scoliosis, altered dermal pigmentation, choreoathetosis, dysmorphic facial features |
2014 | |||||
Complex hereditary spastic paraplegia | B4GALNT1 | β1-4 GalNAc-transferase 1 (GM2) | 609195 | 601873 | early-onset spastic paraplegia, ID, cerebellar ataxia, peripheral neuropathy, cortical atrophy, white matter hyperintensity | 2013 | PMID: 23746551 |
NOR polyagglutination syndrome | A4GALT | α1–4 Gal transferase (GB3 synthase) | 111400 | 607922 | Potential for asymptomatic anemia, leukopenia, or thrombocytopenia | 2012 | PMID: 22965229 |
GALNT2-CDG | GALNT2 | Polypeptide GalNAc Transferase 2 | 618885 | 602274 | Global DD/ID with language deficit, autistic features, behavioral abnormalities, epilepsy, chronic insomnia, white matter changes on brain MRI, dysmorphic features, decreased stature, and decreased high density lipoprotein cholesterol levels | 2020 | PMID: 32293671 |
Adams–Oliver syndrome 4 | EOGT | EGF-domain-specific O-linked O-GlcNAc transferase | 615297 | 614789 | aplasia cutis congenita, terminal transverse limb defects | 2013 | PMID: 23522784 |
Familial tumoral calcinosis | GALNT3 | polypeptide GalNAc-transferase 3 | 211900 | 601756 | massive calcium deposits in skin and tissue | 2004 | PMID: 15133511 |
Tn syndrome | C1GALT1C1 | chaperone of β1-3 GalT | 300622 | 300611 | hemolytic anemia with thrombocytopenia, leukopenia | 2005 | PMID: 16251947 |
Peters plus syndrome | B3GLCT | β1-3 glucosyltransferase–specific for O-fucose on thrombospondin type 1 repeats | 261540 | 610308 | Peters eye anomaly of the anterior chamber, ID, DD, prenatal growth delay, postnatal, typically disproportionately short, cleft lip with or without cleft palate | 2006 | PMID: 16909395 |
Dowling–Degos disease 2 | POFUT1 | protein O-fucosyltransferase 1–specific for particular EGF repeats | 615327 | 607491 | skin disorder showing reticulate hyper- and hypopigmentation at flexure regions such as the neck, axilla, and areas below the breasts and groin | 2013 | PMID: 23684010 |
Dowling–Degos disease 4 | POGLUT1 | protein O-glucosyltransferase 1–specific for particular EGF repeats | 615696 | 615618 | skin disorder showing reticulate hyper- and hypopigmentation at flexure regions such as the neck, axilla, and areas below the breasts and groin | 2014 | PMID: 24387993 |
Autosomal-recessive spondylocostal dysostoses 3 | LFNG | lunatic fringe–specific for O-fucose on particular EGF repeats | 609813 | 602576 | spondylocostal dysostosis with severe vertebral anomalies. | 2006 | PMID: 16385447 |
MRX106 | OGT | O-GlcNAc transferase | 300997 | 300255 | X-linked intellectual disability. | 2017 |
PMID: 28302723
|
NANS deficiency | NANS | N-acetylneuraminic acid synthase | 605202 | infantile-onset severe developmental delay and skeletal dysplasia | 2016 | PMID: 27213289 | |
N-acetylneuraminate pyruvate lyase deficiency | NPL | Recycles sialic acid to ManNAc |
N/A | 611412 | Sialuria, exercise with cardiac symptoms, intolerance/muscle wasting | 2018 | PMID: 30568043 |
GNPNAT1-CDG | GNPNAT1 | Glucosamine-phosphate N-acetyltransferase (converts GlcN-6P to GlcNAc-6P) |
N/A | 616510 | Rhizomelic skeletal dysplasia | 2021 | PMID: 32591345 |
Brain small vessel disease 3 BSVD3 | COLGALT1 | collagen galactosyltransferase | 617531 | Variable onset intracranial bleeding causing DD, spasticity, porencephaly | 2018 |
PMID | |
GOSR2-CDG Epilepsy, progressive myoclonic 6 | GOSR2 | Subunit of SNARE family of vesicle docking proteins | 604027 | Progressive myoclonic epilepsy, ataxia | 2011 | PMID: 21549339 | |
CDG Status Unknown** | |||||||
Galactosemia 1 | GALT | Galactose-1-phosphate uridylyltransferase | 606999 | Failure to thrive, vomiting, cataracts, hepatomegaly, ovarian failure due to hypergonadotropic hypogonadism | 2016 |
PMID | |
Galactosemia 3 | GALE | UDP-galactose-4-prime-epimerase | 606953 | Failure to thrive, hepatomegaly, splenomegaly, Hy, ID, DD, vomiting | 2021 | PMID: 34159722 | |
Fructose intolerance, hereditary | ALDOB | Aldolase B | 612724 | Failure to thrive, hepatomegaly, Hy, ID, DD, Sz vomiting | 2007 | PMID: 17515832 |
*, to be published soon; **, ongoing discussion with clinical and patient advocates; CDG, congenital disorders of glycosylation; CMS, congenital myasthenic syndrome; Dol, dolichol; ID, intellectual disability; Sz, seizures; Hy, hypotonia; M, microcephaly; DD, developmental delay; NSID, nonsyndromic intellectual disability; XLNSID, X-linked nonsyndromic intellectual disability; OST, oligosaccharyltransferase; CMP, cytidine monophosphate; ER, endoplasmic reticulum; CCMS, cerebrocostomandibular-like syndrome; CNS, central nervous system; HIES, hyper-IgE syndrome; CLSD, cranio-lenticulo-sutural dysplasia; CDA, congenital dyserythropoietic anemia; HPMRS, hyperphosphatasia with mental retardation syndrome; CK, creatine kinase; SED, spondyloepimetaphyseal dysplasia; EGF, epidermal growth factor; N/A, not available.
- Known Human Glycosylation Disorders - Essentials of GlycobiologyKnown Human Glycosylation Disorders - Essentials of Glycobiology
Your browsing activity is empty.
Activity recording is turned off.
See more...